https://www.selleckchem.com/pr....oducts/ziritaxestat.
We believe this information is useful to further understand the spread of NL, as well as offering important diagnostic and prognostic information for patients.To systematically evaluate the efficacy and safety of immunoadsorption (IAS) versus non-IAS for systemic lupus erythematosus (SLE) among Chinese population. A meta-analysis was performed by all the literatures germane to estimate the SLE patients treated with IAS and non-IAS from published randomized controlled trials (RCTs) from 1990 to February 2020. Mean differences (MDs),
Mi piace
Commento
Condividi
